The latest announcement is out from Can B ( (CANB) ).
Can B Corp. underwent a holding company reorganization with Nascent Pharma Holdings, Inc. on October 25, 2024, converting all Can B stock into Nascent stock without tax implications for shareholders. The merger, executed under Florida law, transferred Can B’s assets and operations to Nascent, which now registers its shares under the Securities Exchange Act. While a new trading symbol is pending approval from FINRA, Can B’s equity compensation plans have been adjusted to reflect the transition to Nascent.
Learn more about CANB stock on TipRanks’ Stock Analysis page.
